ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Hamad Medical Corporation clinical trials

Also known as HMC.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 139 studies whose lead sponsor is Hamad Medical Corporation. 27 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 2, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Hamad Medical with Staidson (Beijing) Biopharmaceuticals →

Pipeline: 4 programs

Each counted once: 4 with a study Hamad Medical Corporation leads registered in the last two years.

  • Phase 1
  • Phase 4 (approved, new studies)

The 4 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Hamad Medical Corporation’s own registered studies; Hamad Medical Corporation’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Hamad Medical Corporation’s studies test, most open studies first — 45 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 45; every drug is on its own page, and each page lists its sponsors.

Coming up

6 of Hamad Medical Corporation’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. 1J
  9. 1J
  10. A
  11. S
  12. 1O
  13. N

Add all 6 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

All 139 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2719%Recruiting 21 · Not yet recruiting 6
  • Under way, not recruiting32%
  • Completed5137%
  • Stopped early75%Terminated 5 · Withdrawn 2
  • Status unknown or other5137%

Phase

  • Phase 318
  • Phase 417
  • Phase 27
  • Phase 15
  • Early Phase 12

Where

  • Qatar125
  • Bahrain1
  • United States1
  • Jordan1
  • Kuwait1
  • Saudi Arabia1

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 2320
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Hamad Medical Corporation.

  • Hamad Medical Corporation
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    139 studies

Focus areas

Conditions Hamad Medical Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 139. Browse all 139 →